Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Celularity (CELUW) Competitors

Celularity logo
$0.05 +0.00 (+9.89%)
As of 09:40 AM Eastern
Compare

CELUW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Celularity stock or one of its competitors? The main competitors of Celularity include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Celularity vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Celularity$54.22MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Celularity N/A N/A N/A

In the previous week, 180 Life Sciences had 2 more articles in the media than Celularity. MarketBeat recorded 4 mentions for 180 Life Sciences and 2 mentions for Celularity. Celularity's average media sentiment score of 1.88 beat 180 Life Sciences' score of 0.98 indicating that Celularity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
180 Life Sciences
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Celularity
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Celularity beats 180 Life Sciences on 2 of the 3 factors compared between the two stocks.

Get Celularity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELUW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CELUW vs. The Competition

Export to Excel
MetricCelularityBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$138.28M$5.57B$9.81B
Dividend YieldN/A3.74%4.62%4.12%
P/E RatioN/A3.7829.8025.74
Price / SalesN/A4,277.04460.01111.33
Price / CashN/A13.1937.7558.93
Price / BookN/A42.888.496.01
Net IncomeN/A-$90.99M$3.25B$264.84M
7 Day PerformanceN/A1.73%3.71%2.66%
1 Month PerformanceN/A3.46%4.03%1.56%
1 Year PerformanceN/A182.34%35.47%29.07%

Celularity Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELUW
Celularity
N/A$0.05
+9.9%		N/AN/A$0.00$54.22M0.00220News Coverage
Positive News
Gap Down
ATNFW
180 Life Sciences
N/A$0.01
+1.0%		N/A+6,690.1%$0.00N/A0.007News Coverage
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+84.9%		N/AN/A$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.35
+220.2%		N/AN/A$0.00$106.21K0.0040Gap Up
High Trading Volume
ALVOW
Alvotech
N/A$1.31
-18.1%		N/A-47.5%$0.00$585.60M0.004Gap Down
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
+2.9%		N/A-62.3%$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.14
-9.9%		N/AN/A$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.02
+19.3%		N/A-97.8%$0.00$199.38M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.03
-27.9%		N/A-86.3%$0.00N/A0.008Negative News
Short Interest ↓
Gap Down
High Trading Volume

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CELUW) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners
Generate up to $5,000/month with 10X less money?
The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...
Investors Alley | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsored
Get This Stock Now
This company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...
InvestorPlace | Sponsored
National 'Stock Market Reset' Coming September 30 (New WH Order)
Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...
Altimetry | Sponsored
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsored
The stealth altcoin the financial world is underestimating
This DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...
Crypto 101 Media | Sponsored